A detailed history of Keybank National Association transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Keybank National Association holds 4,328 shares of CRL stock, worth $871,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,328
Previous 4,946 12.49%
Holding current value
$871,226
Previous $1.02 Million 16.55%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$187.96 - $245.29 $116,159 - $151,589
-618 Reduced 12.49%
4,328 $852,000
Q2 2024

Jul 31, 2024

BUY
$206.39 - $268.73 $35,911 - $46,759
174 Added 3.65%
4,946 $1.02 Million
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $20,759 - $27,889
-102 Reduced 2.09%
4,772 $1.29 Million
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $75,679 - $109,866
460 Added 10.42%
4,874 $1.15 Million
Q3 2023

Nov 08, 2023

SELL
$194.44 - $217.61 $2,333 - $2,611
-12 Reduced 0.27%
4,414 $865,000
Q2 2023

Aug 01, 2023

BUY
$183.71 - $210.25 $2,388 - $2,733
13 Added 0.29%
4,426 $930,000
Q1 2023

May 10, 2023

BUY
$191.89 - $259.92 $37,418 - $50,684
195 Added 4.62%
4,413 $890,000
Q4 2022

Jan 31, 2023

BUY
$197.11 - $250.07 $87,319 - $110,781
443 Added 11.74%
4,218 $918,000
Q3 2022

Oct 27, 2022

BUY
$182.44 - $250.54 $70,604 - $96,958
387 Added 11.42%
3,775 $743,000
Q2 2022

Aug 08, 2022

SELL
$204.13 - $302.4 $52,461 - $77,716
-257 Reduced 7.05%
3,388 $725,000
Q1 2022

Apr 28, 2022

SELL
$255.51 - $362.11 $15,075 - $21,364
-59 Reduced 1.59%
3,645 $1.04 Million
Q4 2021

Feb 07, 2022

BUY
$351.38 - $448.68 $19,325 - $24,677
55 Added 1.51%
3,704 $1.4 Million
Q3 2021

Nov 08, 2021

BUY
$372.64 - $458.3 $3,726 - $4,583
10 Added 0.27%
3,649 $1.51 Million
Q2 2021

Aug 12, 2021

BUY
$294.17 - $371.65 $34,123 - $43,111
116 Added 3.29%
3,639 $1.35 Million
Q1 2021

May 07, 2021

BUY
$249.67 - $299.48 $1,248 - $1,497
5 Added 0.14%
3,523 $1.02 Million
Q4 2020

Feb 09, 2021

BUY
$222.0 - $252.62 $62,382 - $70,986
281 Added 8.68%
3,518 $879,000
Q3 2020

Oct 29, 2020

BUY
$175.56 - $226.45 $93,573 - $120,697
533 Added 19.71%
3,237 $733,000
Q2 2020

Aug 10, 2020

SELL
$118.84 - $189.72 $12,953 - $20,679
-109 Reduced 3.87%
2,704 $471,000
Q1 2020

May 13, 2020

SELL
$98.9 - $178.34 $8,406 - $15,158
-85 Reduced 2.93%
2,813 $355,000
Q4 2019

Feb 05, 2020

BUY
$126.05 - $152.76 $6,302 - $7,638
50 Added 1.76%
2,898 $443,000
Q3 2019

Nov 04, 2019

SELL
$125.07 - $143.67 $19,886 - $22,843
-159 Reduced 5.29%
2,848 $377,000
Q2 2019

Aug 01, 2019

SELL
$123.4 - $148.55 $493 - $594
-4 Reduced 0.13%
3,007 $427,000
Q1 2019

May 08, 2019

BUY
$104.82 - $146.73 $209 - $293
2 Added 0.07%
3,011 $437,000
Q4 2018

Jan 30, 2019

SELL
$105.09 - $137.23 $6,725 - $8,782
-64 Reduced 2.08%
3,009 $341,000
Q3 2018

Nov 08, 2018

BUY
$112.11 - $134.54 $19,507 - $23,409
174 Added 6.0%
3,073 $413,000
Q2 2018

Aug 08, 2018

SELL
$102.37 - $117.25 $8,701 - $9,966
-85 Reduced 2.85%
2,899 $325,000
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $6,284 - $7,372
64 Added 2.19%
2,984 $319,000
Q4 2017

Feb 08, 2018

SELL
$100.43 - $118.09 $401 - $472
-4 Reduced 0.14%
2,920 $320,000
Q3 2017

Nov 02, 2017

BUY
$96.72 - $109.26 $282,809 - $319,476
2,924
2,924 $316,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.